Novo Holdings participates in EUR 110 million first closing of Sound Bioventures Fund I
Copenhagen, Denmark – Novo Holdings, a leading international life sciences investor, today announced that it has invested in Sound Bioventures Fund I as cornerstone investor in the first close of EUR 110 million.
Sound Bioventures will be investing in private biotech companies and will focus on companies with assets in clinical or late pre-clinical stages, primarily within rare diseases.
